215 related articles for article (PubMed ID: 23884057)
1. Hepatitis C virus reinfection following treatment among people who use drugs.
Grady BP; Schinkel J; Thomas XV; Dalgard O
Clin Infect Dis; 2013 Aug; 57 Suppl 2():S105-10. PubMed ID: 23884057
[TBL] [Abstract][Full Text] [Related]
2. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
Islam N; Krajden M; Shoveller J; Gustafson P; Gilbert M; Buxton JA; Wong J; Tyndall MW; Janjua NZ;
Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):200-210. PubMed ID: 28404135
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C Reinfection in People Who Inject Drugs in Resource-Limited Countries: A Systematic Review and Analysis.
Muller A; Vlahov D; Akiyama MJ; Kurth A
Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32659974
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort.
Rossi C; Butt ZA; Wong S; Buxton JA; Islam N; Yu A; Darvishian M; Gilbert M; Wong J; Chapinal N; Binka M; Alvarez M; Tyndall MW; Krajden M; Janjua NZ;
J Hepatol; 2018 Nov; 69(5):1007-1014. PubMed ID: 30142429
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs.
Weir A; McLeod A; Innes H; Valerio H; Aspinall EJ; Goldberg DJ; Barclay ST; Dillon JF; Fox R; Fraser A; Hayes PC; Kennedy N; Mills PR; Stanley AJ; Aitken C; Gunson R; Templeton K; Hunt A; McIntyre P; Hutchinson SJ
Drug Alcohol Depend; 2016 Aug; 165():53-60. PubMed ID: 27268294
[TBL] [Abstract][Full Text] [Related]
6. Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam.
Grady BP; Vanhommerig JW; Schinkel J; Weegink CJ; Bruisten SM; Lindenburg CE; Prins M
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1302-7. PubMed ID: 22825643
[TBL] [Abstract][Full Text] [Related]
7. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.
Micallef JM; Macdonald V; Jauncey M; Amin J; Rawlinson W; van Beek I; Kaldor JM; White PA; Dore GJ
J Viral Hepat; 2007 Jun; 14(6):413-8. PubMed ID: 17501762
[TBL] [Abstract][Full Text] [Related]
8. High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.
Aitken CK; Lewis J; Tracy SL; Spelman T; Bowden DS; Bharadwaj M; Drummer H; Hellard M
Hepatology; 2008 Dec; 48(6):1746-52. PubMed ID: 18844233
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for the management of hepatitis C virus infection among people who inject drugs.
Robaeys G; Grebely J; Mauss S; Bruggmann P; Moussalli J; De Gottardi A; Swan T; Arain A; Kautz A; Stöver H; Wedemeyer H; Schaefer M; Taylor L; Backmund M; Dalgard O; Prins M; Dore GJ;
Clin Infect Dis; 2013 Aug; 57 Suppl 2():S129-37. PubMed ID: 23884061
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis.
Aspinall EJ; Corson S; Doyle JS; Grebely J; Hutchinson SJ; Dore GJ; Goldberg DJ; Hellard ME
Clin Infect Dis; 2013 Aug; 57 Suppl 2():S80-9. PubMed ID: 23884071
[TBL] [Abstract][Full Text] [Related]
11. Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow.
McDonald SA; Hutchinson SJ; Cameron SO; Innes HA; McLeod A; Goldberg DJ
Int J Drug Policy; 2012 Sep; 23(5):353-7. PubMed ID: 22421553
[TBL] [Abstract][Full Text] [Related]
12. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011.
Iversen J; Grebely J; Topp L; Wand H; Dore G; Maher L
J Viral Hepat; 2014 Mar; 21(3):198-207. PubMed ID: 24438681
[TBL] [Abstract][Full Text] [Related]
13. HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment.
Walsh N; Maher L
Curr Opin HIV AIDS; 2012 Jul; 7(4):339-44. PubMed ID: 22498482
[TBL] [Abstract][Full Text] [Related]
14. Frequent multiple hepatitis C virus infections among injection drug users in a prison setting.
Pham ST; Bull RA; Bennett JM; Rawlinson WD; Dore GJ; Lloyd AR; White PA
Hepatology; 2010 Nov; 52(5):1564-72. PubMed ID: 21038409
[TBL] [Abstract][Full Text] [Related]
15. Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs.
Cunningham EB; Hajarizadeh B; Amin J; Hellard M; Bruneau J; Feld JJ; Cooper C; Powis J; Litwin AH; Marks P; Dalgard O; Conway B; Moriggia A; Stedman C; Read P; Bruggmann P; Lacombe K; Dunlop A; Applegate TL; Matthews GV; Fraser C; Dore GJ; Grebely J
Clin Infect Dis; 2021 Apr; 72(8):1392-1400. PubMed ID: 32166305
[TBL] [Abstract][Full Text] [Related]
16. High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units.
Valencia J; Alvaro-Meca A; Troya J; Cuevas G; Gutiérrez J; Morro A; Alvarez J; Pulido L; Cañamares I; Escobar I; Moreno S; Ryan P
Int J Drug Policy; 2019 Oct; 72():181-188. PubMed ID: 31253391
[TBL] [Abstract][Full Text] [Related]
17. The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs.
Aitken CK; Agius PA; Higgs PG; Stoové MA; Bowden DS; Dietze PM
Epidemiol Infect; 2017 Mar; 145(4):796-801. PubMed ID: 27927256
[TBL] [Abstract][Full Text] [Related]
18. A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus.
Currie SL; Ryan JC; Tracy D; Wright TL; George S; McQuaid R; Kim M; Shen H; Monto A
Drug Alcohol Depend; 2008 Jan; 93(1-2):148-54. PubMed ID: 17977668
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus reinfection in injection drug users.
Grebely J; Conway B; Raffa JD; Lai C; Krajden M; Tyndall MW
Hepatology; 2006 Nov; 44(5):1139-45. PubMed ID: 17058216
[TBL] [Abstract][Full Text] [Related]
20. Mixed HCV infection and reinfection in people who inject drugs--impact on therapy.
Cunningham EB; Applegate TL; Lloyd AR; Dore GJ; Grebely J
Nat Rev Gastroenterol Hepatol; 2015 Apr; 12(4):218-30. PubMed ID: 25782091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]